Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.
Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer.
Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practic